glp-1 gastroparesis class action in michigan The FDA sent a warning letter to the maker of Ozempic and Wegovy over unreported potential side effects. Here's what to know GLP-1 Manufacturers Argue Gastroparesis Lawsuits

DFG TI239/16-1 (PI Timmann)) Ethics declarations Conflicts of Interest LN Miterko, J Beckinghausen, RV Sillitoe: None LV Bradnam, AB McCambridge: None J Cooperrider, KB Baker, A Machado: None M Hallett: Member of the scientific advisory board of Brainsway T Popa: None DH Heck: None T Wichmann, MR DeLong: None SV Gornati, FE Hoebeek: None AZ Kouzani: None S-H Kuo, T Xie, ED Louis: None M Manto, N Oulad Ben Taib: None MA Nitsche: Member of the scientific advisory board of Neuroelectrics M Tanaka: None D Timmann: None MY Cheng, EH Wang, GK Steinberg: None Additional information Publishers Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

When considering adding an nsMRA for an individual with diabetic nephropathy and persistently elevated albuminuria, the risk of hyperkalemia must be considered with finerenone

Journal of Biological Chemistry 286, 44934499 (2011)

doi: 10.1074/jbc.M115.700534 16 YooHCParkSJNamMKangJKimKYeoJHet al